Radar HealthTech | Sdli
  • Sdli
  • Nuestros Clientes
  • Nuestro equipo
  • Radar Sdli
  • Blog Sdli
  • Escríbenos!
Seleccionar página
Pfizer Commits to Empowering Clinical Trial Participants with Access to Their Data

Pfizer Commits to Empowering Clinical Trial Participants with Access to Their Data

por Sdli Scouter | Sep 22, 2023 | Sector and Trends

Summary: Pfizer has announced its commitment to provide clinical trial participants with consistent and reliable access to their individual data through its Participant Data Return initiative. This initiative acknowledges the importance of empowering participants with...
This is the GPT Health Chat for asthma treatment

This is the GPT Health Chat for asthma treatment

por Sdli Scouter | Sep 20, 2023 | Digital Patient, Health Management

Summary: The Health ChatGPT, known as iaGEMA, is now a reality and is set to revolutionize clinical practice in the field of asthma prevention. Developed in collaboration with the Spanish guide for treating asthma (GEMA 5.3) and Luzán 5 Health Advice, this innovative...
Digital Health in Europe: WHO Report Highlights Progress and Challenges

Digital Health in Europe: WHO Report Highlights Progress and Challenges

por Sdli Scouter | Sep 20, 2023 | Sector and Trends

Summary: In a significant stride towards modernizing healthcare systems, the World Health Organization (WHO) has unveiled its latest report, offering a comprehensive analysis of the Digital Health landscape in the European Region. The report sheds light on various...
NHS uses AI Tool to Predict Long-Staying Hospital Patients in the UK

NHS uses AI Tool to Predict Long-Staying Hospital Patients in the UK

por Sdli Scouter | Sep 20, 2023 | Prevention

Summary: The UK’s National Health Service (NHS) is exploring the use of artificial intelligence (AI) to predict when patients are at risk of experiencing extended hospital stays. This initiative, developed in collaboration with the Accelerated Capability...
Pfizer crea un asistente virtual para acompañar y apoyar a los pacientes con Mieloma Múltiple

Pfizer crea un asistente virtual para acompañar y apoyar a los pacientes con Mieloma Múltiple

por Sdli Scouter | Sep 14, 2023 | Health Management

Summary: En 2023, se espera que aproximadamente 3,000 personas en España sean diagnosticadas con mieloma múltiple, convirtiéndolo en el tercer cáncer hematológico más común en el país. Este tipo de cáncer no solo tiene un impacto físico en los pacientes, sino que...
« Entradas más antiguas
Entradas siguientes »

© -2026 | Sdli